The NUB reimbursement pathway has been effective in bringing high-cost innovative medical technologies to the German market, but there are challenges. In MedTech Strategist, we assess the funding of medtech through NUBs and outlines the strengths and weaknesses of the NUB pathway.
Overcoming the funding challenges of bringing digital health technologies to market
Digital health is a rapidly emerging field showing significant potential to improve the quality and efficiency of healthcare systems around the world, and more...